Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Open Access

Clinical Experience with Gastrointestinal Stromal Tumors: A Retrospective Analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

ÖBÖmer BaşolİÖİbrahim Halil ÖcalHAHüseyin Alakuş

Discussion

Loading...

Member takes

Overview

Retrospective analysis of surgical outcomes and risk factors in patients with gastrointestinal stromal tumors, indicating the need for effective management strategies.

Key Points

  • Adjuvant imatinib treatment reduces recurrence rates in patients with high-risk gastrointestinal stromal tumors.
  • Among 49 patients, 57.1% were male, and tumor sizes ranged, with 22.4% measuring 10 cm or larger.
  • The majority of tumors were found in the small intestine (36%) and stomach (34%), with 52% classified as low risk.
  • Effective surgical treatment, along with precise risk assessment, is crucial for managing gastrointestinal stromal tumors.

Cite This Study

Başol et al. (2025) studied this question.

synapsesocial.com/papers/68c1bb6354b1d3bfb60ed017https://doi.org/10.20944/preprints202508.0174.v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Retrospective Evaluation of Demographic and Clinical Features of Gastrointestinal Stromal Tumors2026
  2. 2Epidemiological, Diagnostic and Therapeutic Aspects of Gastro-Intestinal Stromal Tumor, About 16 Cases2025
  3. 3Prognostic Factors for Survival in Surgically Treated Patients with Gastrointestinal Stromal Tumors: A Single-Center 15-Year Retrospective Analysis2026
  4. 4Gastrointestinal Stromal Tumors: From Diagnosis to Adjuvant Therapy2024
  5. 5Retrospective analysis of clinicopathological characteristics and survival outcome of gastrointestinal stromal tumors: Real-world experience2026